Zenji Makita
Publications by Year
Research Areas
Advanced Glycation End Products research, Natural Antidiabetic Agents Studies, Chronic Kidney Disease and Diabetes, Diabetes, Cardiovascular Risks, and Lipoproteins, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Advanced Glycosylation End Products in Patients with Diabetic Nephropathy(1991)921 cited
- → Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury(2003)705 cited
- → Lipid advanced glycosylation: pathway for lipid oxidation in vivo.(1993)575 cited
- → Immunochemical detection of advanced glycosylation end products in vivo.(1992)491 cited
- → Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.(1994)473 cited
- → Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Diseases(1998)400 cited
- → Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.(1992)382 cited
- → Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure(1994)372 cited
- High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers.(2002)
- → Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial Cells(2002)311 cited